TRACON Pharmaceuticals Inc

TCON 4.81
0.05 (1.0%)

Open: 5.22 High: 5.32 Low: 4.72

9 x 4.81 = 43.29
x $4.81 =

NASDAQ: TCON $70 Million Small-Cap. Health Care Sector. Biotech & Pharma Industry. 5 Year Return 61%. 1 Year Return 928%. 2020 YTD Return 78%. Since Earnings 144%.

ST

External Links

Free Channels & more...

For Starters

Charts

image
image

52WL $0.28

The 52 Week Low is $0.28 set on Wed, Oct 23, 2019.

52WH $6.37

The 52 Week High is $6.37 set on Fri, Sep 18, 2020.

ATH $21.00

The All-Time High is $21.00 set on Tue, Mar 3, 2015.

52 Week Range

$0.28
$6.37
Oct 23, 2019
Sep 18, 2020

Earnings

-0.70

Earnings Per Share

0.00

Price To Earnings Ratio


for

Wed, Dec 31, 1969

Since Report


Q2 Earnings for Apr, May & Jun

Wed, Aug 5, 2020

Since Q2 Earnings Report

TCON 147.9%

Dividends

0.00

Dividend Yield

0.00

Dividend Rate

--

Ex-Dividend Date

--

Dividend Payment Date

--

Dividend Frequency

0

Dividend History

Profile

TRACON Pharmaceuticals Inc trades on the NASDAQ. TCON's market cap is 60.00 Million.

TRACON Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of novel targeted therapeutics for cancer and wet age-related macular degeneration (wet AMD). The company's pipeline consists of product candidates such as TRC105, TRC102, TRC253, TRC694, and TRC205. The lead product TRC105 is an endoglin antibody, for the treatment of multiple solid tumor types in combination with inhibitors of the vascular endothelial growth factor pathway, or programmed cell death protein 1 pathway.

Website

Related Channels

Account Channels

Track your portfolio and more.